Form 4/A for CLB Core Laboratories Inc. /DE/
Accepted 2024-01-08 00:00:00 ET · period of report 2023-12-31 · accession 0000950170-24-002882 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-01-08 | 2023-12-31 | CLB | Bruno Lawrence | COB, CEO, Dir | F - Tax | $17.66 | -39.4K | 163.2K | -19% | -$695.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-31 | F | D | 39,373 | $17.66 | 163,203 | D | — | — | (F1) The original Form 4, filed on January 3, 2024, is being amended by this Form 4 amendment to correct an administrative error of the issuer, whereupon the number of shares withheld to satisfy tax withholding obligations upon vesting of certain restricted performance shares was misreported as 38,473 shares. The corrected transaction reflects an increase of 900 shares withheld by the issuer as a result such vesting and a corresponding reduction in the number of shares beneficially owned by the reporting person. |